UK makes £30m investment in T-Cell cancer therapy
January 22, 2015Research and Development, Sales and Marketing Autolus, Cancer, London, T cell, UK, government, oncology, syncona
The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …
EMA launches consultation on clinical trials
January 22, 2015Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency
The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …
New chief executive for AiCuris
January 22, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, Holger Zimmermann, Rübsamen-Schaeff
Founded in 2006 as a spin-off from Bayer, AiCuris has found a new chief executive as Helga Rübsamen-Schaeff steps aside …
Olysio and Xarelto boost J&J’s Q4
January 21, 2015Sales and Marketing J&J, JJ, Janssen, NICE, Remicade, Velcade, Xarelto, financials, hep C, olysio, q4, quarter four
Johnson & Johnson earned a 10% increase in worldwide sales of its drugs in the last quarter of 2014 compared …
Gilead and Strides partner in HIV
January 21, 2015Research and Development, Sales and Marketing Cipla, FDA, Gilead, HIV, Ranbaxy, Tenofovir Alafenamide, WHO, strides, taf
Gilead is partnering with India-based pharma firm Strides Arcolab in a licensing agreement to manufacture and distribute an HIV treatment …
UCB epilepsy drug reaches regulatory bodies
January 21, 2015Research and Development, Sales and Marketing EMA, FDA, UCB, brivaracetam, epilepsy
UCB has established regulatory milestones for its investigational antiepileptic drug brivaracetam in Europe and the US. The Food and Drug …
Biotec Services International, a PCI company, Completes First Phase of EU Clinical Supplies Facility Expansion
January 21, 201512 December 2014, Bridgend, UK. Biotec Services International has completed validation of their latest clinical supply facility expansion. The specification …
BMS names operating officer as new chief executive
January 21, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Giovanni Caforio, Lamberto Andreotti, Yervoy, opdivo
Bristol-Myers Squibb’s chief operating officer Giovanni Caforio will be stepping in to Lamberto Andreotti’s shoes as chief executive from May …
Tauriga Sciences adds venture capitalist
January 21, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hingge Hsu, tauriga sciences
US life sciences firm Tauriga Sciences has appointed Dr Hingge Hsu to its board of directors. Hsu was recently a …
MSF hits out at ‘astronomical’ vaccine prices
January 20, 2015Research and Development, Sales and Marketing Doctors Without Borders, GSK, Médicines San Frontières, Pfizer, Vaccine, diphtheria, measles, pertussis, poliomyelitis, tetanus, tuberculosis
Pharma companies have been named and shamed in a report calling on manufacturers to lower the cost of childhood vaccines …
Bioscience lab opens up in Cambridge
January 20, 2015Research and Development AstraZeneca, BIA, Babraham Research Campus, Cambridge, Menelas Pangalos
The UK Bennet Building bioscience laboratory doors have been opened during a ceremony at the Babraham Research Campus in Cambridge …
Hospira closing US manufacturing plant
January 20, 2015Manufacturing and Production, Sales and Marketing Clayton, Hospira, Novo Nordisk, Vancomycin hydrochloride, illinois, manufacturing
US injectable drugs specialist Hospira is to close its Clayton plant in North Carolina affecting 250 workers. Manufacturing of products …
New vice-chair for Commission on Human Medicines
January 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Commission on Human Medicines, angela thomas, chm
Dr Angela Thomas has been appointed as vice-chair of the Commission on Human Medicines (CHM).She replaces Professor Ian Weller who …
Regulators ‘more efficient at approving drugs’
January 19, 2015Research and Development, Sales and Marketing EMA, EMA), FDA, Health Canada, PMDA)., Pharmaceutical and Medical Devices Agency, Swissmedic, TGA, approvals, cirs, reuters
Global regulatory bodies have become faster at approving new drug products more quickly and consistently, according to a new analysis …
Genentech and Human Longevity ink genomics deal
January 19, 2015Research and Development, Sales and Marketing 23andME, DNA, Genentech, Illumina, hli, human longevity
Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …
Boehringer gains EU approval for Ofev
January 19, 2015Sales and Marketing Boehringer, Esbriet, IPF, InterMune, ingelheim, nintedanib, ofev
The European Commission has approved Boehringer Ingelheim’s Ofev as a treatment for idiopathic pulmonary fibrosis (IPF). The approval follows the …
Roche buys French biotech for €470 million
January 19, 2015Sales and Marketing Foundation, Genentech, Orphan, Roche, TRO19622, olesoxime, sma, trophos
Roche is buying France-based biotech Trophos in a deal worth up to €470 million in order to gain access to …
Astellas takes senior head from AstraZeneca
January 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, AstraZeneca, eric Terhaerdt
Eric Terhaerdt has been named as the senior vice president of global development operations at Astellas Pharma. Terhaerdt, who joins the …
Interview: Rajeev Venkayya, president of Takeda Vaccine
January 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bush, Ebola, Gates, Rajeev Venkayya, Takeda, brett wells, vaccines
Rajeev Venkayya is the president of the global vaccine business unit at Takeda Pharmaceuticals. He has served as special assistant …
AbbVie Hep C combo pill ready for Europe
January 16, 2015Medical Communications AbbVie, Exviera, FDA, HIV, Viekira Pak, Viekirax, harvoni, hep C, sovaldi
The European Commission has approved AbbVie’s Viekirax and Exviera for the treatment of chronic hepatitis C (HCV). Viekirax (ombitasvir/paritaprevir/ritonavir) and …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
